Plot No.367, Abhey Pur, Industrial Area Phase-1, Panchkula, Haryana 134109
Don't miss out on this limited-time offer to join our successful PCD Pharma network. Fill in your details below and our team will get in touch with you to discuss the best franchise opportunities tailored to your needs.
Ketorolac (0.4% w/v) + Olopatadine (0.1% w/v)
Therapeutic Category
Anti-Inflammatories, Ophthalmology, Analgesics, Antihistamines
Dosage Form
Eye Drops
Packaging Type
Dropper
Packaging
5ml
Price
₹239/-
High-resolution images and Product visuals
Product overview and usage information
Detailed information and research documents
Oloplit KT Eye Drops contain Ketorolac (0.4% w/v), a non-steroidal anti-inflammatory agent, and Olopatadine (0.1% w/v), an antihistamine. Ketorolac helps reduce inflammation and pain in the eyes, while Olopatadine blocks histamine, relieving itching, redness, and allergic reactions.
It helps in relieving symptoms of allergic conjunctivitis, eye itching, redness, watering, irritation, and inflammation caused by seasonal or perennial allergens.
May cause mild burning, stinging, or temporary blurred vision after application. Rarely, headache, eye irritation, or dry eyes may occur.
Indicated for patients experiencing eye allergies with inflammation, itching, redness, or watery eyes. Suitable for adults and children as per physician’s guidance.
Use only under medical supervision. Avoid touching the dropper tip to any surface or the eye to prevent contamination. Remove contact lenses before application unless advised otherwise. Inform your doctor of any history of eye disorders or allergies.
Store below 25°C in a cool, dry place, protected from light. Keep out of reach of children. Discard the bottle as per instructions after the recommended duration of use.
Composition : Sodium Carboxymethylcellulose I.P. 0.5% w/v + Oxychloro Complex 0.0075% v/v (As Perservatives) + Sterile Aqueous Base Eye Drop
Composition : Timolol (5mg) + Brimonidine (2mg) Eye Drop
Composition : Timolol (0.5% w/v) Eye Drop
Composition : Loteprednol etabonate (0.5% w/v) + Tobramycin (0.3% w/v)
Composition : Fluconazole (0.3% w/v)
Composition : Ketorolac (0.5% w/v)
Composition : Carboxymethylcellulose (1% w/v) + Oxychloro Complex (0.0075% w/v)
Composition : Moxifloxacin HCL I.P. 0.5% w/v + Ketorolac Tromethsmine I.P. 5% w/v Eye Drop
Composition : Loteprednol etabonate (0.5% w/v) + Moxifloxacin (0.5% w/v)
This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.
This combination has strong demand in the ENT and ophthalmology segment, making it a valuable product for medical distributors, wholesalers, and pharma franchise partners focusing on eye and ear-care portfolios.
Medical distributors and agencies can benefit from consistent demand for management of allergic conjunctivitis, eye irritation, ear itching, allergic ear conditions, inflammation, and seasonal allergies affecting eyes and ears. Ketorolac 0.4% helps reduce inflammation and pain (NSAID action) Olopatadine 0.1% helps control allergic reactions, itching, and redness This combination strengthens a dual-purpose ophthalmic and ENT anti-allergy portfolio.
Yes, Cafoli LifeCare Pvt Ltd offers PCD pharma franchise opportunities for Ketorolac + Olopatadine Eye & Ear Drops with promotional support, monopoly rights, attractive packaging, and competitive pricing for distributors and wholesalers.
Wholesalers and medical agencies benefit from strong ENT and ophthalmologist prescriptions, seasonal allergy demand, fast-moving OTC sales, hospital and clinic usage, reliable supply chain support, and good margins in eye and ear-care medicines.
Interested distributors, stockists, and wholesalers can contact Cafoli LifeCare Pvt Ltd to discuss pricing, monopoly territory rights, and distribution opportunities.